Castleark Management LLC Takes $9.48 Million Position in Ralliant Corporation $RAL

Castleark Management LLC acquired a new stake in Ralliant Corporation (NYSE:RAL) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 128,740 shares of the company’s stock, valued at approximately $9,479,000. Castleark Management LLC owned 0.12% of Ralliant as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the company. Danske Bank A S bought a new position in shares of Ralliant during the 4th quarter valued at about $25,000. Dunhill Financial LLC bought a new stake in Ralliant during the second quarter worth approximately $25,000. Allworth Financial LP grew its position in Ralliant by 134.4% in the fourth quarter. Allworth Financial LP now owns 511 shares of the company’s stock worth $26,000 after buying an additional 293 shares during the last quarter. Palisade Asset Management LLC acquired a new position in Ralliant in the third quarter worth approximately $26,000. Finally, BOKF NA bought a new position in shares of Ralliant in the third quarter valued at $29,000.

Ralliant Price Performance

NYSE RAL opened at $61.87 on Wednesday. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.52 and a quick ratio of 1.00. The firm has a market capitalization of $6.85 billion, a price-to-earnings ratio of -5.70, a price-to-earnings-growth ratio of 2.34 and a beta of 1.60. The company has a 50 day simple moving average of $68.69 and a 200-day simple moving average of $56.04. Ralliant Corporation has a 52-week low of $37.27 and a 52-week high of $75.41.

Ralliant (NYSE:RAL) last released its quarterly earnings data on Thursday, July 30th. The company reported $0.68 earnings per share for the quarter, beating the consensus estimate of $0.63 by $0.05. The firm had revenue of $567.80 million for the quarter. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. Equities research analysts predict that Ralliant Corporation will post 2.87 earnings per share for the current fiscal year.

Ralliant Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a dividend of $0.05 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. Ralliant’s dividend payout ratio (DPR) is presently -1.84%.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Truist Financial reissued a “buy” rating and set a $82.00 price objective (up from $68.00) on shares of Ralliant in a research note on Friday, July 31st. TD Cowen lifted their price target on Ralliant from $70.00 to $80.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. Weiss Ratings restated a “sell (d)” rating on shares of Ralliant in a report on Friday, July 31st. Barclays raised their target price on shares of Ralliant from $52.00 to $67.00 and gave the stock an “overweight” rating in a report on Wednesday, May 13th. Finally, Oppenheimer lifted their target price on shares of Ralliant from $50.00 to $65.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $75.70.

Insiders Place Their Bets

In other news, CEO Tamara S. Newcombe sold 12,936 shares of the firm’s stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $71.79, for a total transaction of $928,675.44. Following the completion of the sale, the chief executive officer directly owned 251,967 shares of the company’s stock, valued at $18,088,710.93. This trade represents a 4.88% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Karen M. Bick sold 6,062 shares of Ralliant stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $72.00, for a total value of $436,464.00. Following the sale, the senior vice president owned 31,668 shares of the company’s stock, valued at approximately $2,280,096. This represents a 16.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.42% of the stock is currently owned by company insiders.

Ralliant Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.